Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06508268

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Language, Speech and Motor Function in Mild Cognitive Impairment Due to AD and Alzheimer's Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
208 (estimated)
Sponsor
Hanze University of Applied Sciences Groningen · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The goal of this observational cross-sectional study is to explore the characteristics of language, speech, and motor function in persons with Mild Cognitive Impairment due to Alzheimer's disease ("MCI due to AD") and persons with mild and moderate Alzheimer's disease ("AD"). This study aims to: * Explore motor, speech, and language functions in MCI due to AD and mild and moderate AD. * Combine the characteristics of motor, language, and speech functions to gain more insight into the association of language, speech, and motor changes during MCI due to AD and mild and moderate AD. Researchers will compare the outcomes to an age-matched control group without cognitive impairment. Participants will undergo: * Two motor function tests to assess gait and hand grip strength. * Four language and speech function tests to assess spontaneous speech and verbal fluency..

Conditions

Interventions

TypeNameDescription
BEHAVIORALGAITRite walkway system OR 4-meter walking speed testGait will be assessed by the GAITRite walkway system OR the 4-meter walking speed test
BEHAVIORALJamar hand dynamometerHand grip strength will be assessed by a Jamar hand dynamometer
BEHAVIORALPicture description taskCharacteristics Dutch/Frisian language Language and speech will be assessed by the Cookie Theft Picture-task (a picture description task from Berube et al., 2019)
BEHAVIORALAutobiographical semi-structured conversationCharacteristics Dutch/Frisian language and speech will be assessed by an autobiographical semi-structured conversation
BEHAVIORALVerbal fluencyThe mental lexicon of Dutch/Frisian language will be assessed by a two verbal fluency tests, including letter fluency and categorical fluency

Timeline

Start date
2024-07-12
Primary completion
2025-02-09
Completion
2025-02-09
First posted
2024-07-18
Last updated
2024-07-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06508268. Inclusion in this directory is not an endorsement.